If we are to go off the RSI then you could argue that a pull back next day or so could occur on LH before rallying up. I started receiving notifications from awesomesto-cks the other week and so far they have presented interesting new trade ideas.
Laboratory Corp_ of America Ho NYSE $LH Correlation Histogram
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stocks
NEW $ Target: On March 07(th) , 2017, research firm Barclays reiterated its 'Overweight' rating on the Company's stock with an increase of the target price from $165 a share to $175 a share. The complimentary research report on LH can be downloaded at:
LH appears to suggest upside opportunity. I started receiving notifications from awesome-STOCKS the other week and so far they have presented interesting new trade ideas.
LH-said its earnings and sales rose in the most recent quarter.
The company also gave an upbeat 2017 outlook, forecasting adjusted earnings of $9.35 to $9.75 on revenue growth of 4.5% to 6.5%. Analysts polled by Thomson Reuters were expecting $9.63 on 4.4% revenue growth.
In all for the fourth quarter Laboratory Corp. reported a profit of $184.4 million, or $1.75 a share, up from $110 million, or $1.07, a year earlier. Excluding certain items, earnings rose to $2.15 from $1.98 cents. Revenue grew 6.3% to $2.39 billion.
Downside risk pretty much eliminated now that LH has seen eps estimate for next year reached the lower limits of 9.63. Not sure how awesomeS-TOCKS finds all these incredible trade ideas but im happy.
Crush the NASDAQ & NYSE with the Biggest Winners from PennySt0ck101.0rg
1/23/17-Laboratory Corporation Price Target Announced at $170.00/Share by Deutsche Bank
Last SPLIT was 2002 (2 for 1) -STILL ONLY 100Million Shares outstanding. IMHO_ IF another SPLIT is announced-it could be around Dec. 9th--which would be ex-div. date (if Div. was forthcoming) IMHO- Theranos Departure from Lab Diagnostics-has helped LH icrease Market Share....
Laboratory of America Holdings (NYSE:LH) - Fundamentals Analysis
Laboratory of America Holdings (NYSE:LH): Undervalued with proven track record. Simply Wall St is a free app which gives investors access to institutional quality data and analysis presented in beautiful visual reports.
S&P Capital NEW LH PRICE TARGET: 12-month target of $155, 15.8X our '17 EPS estimate. This multiple is a premium to peers, justified by our above average sales growth outlook. ***We raise our '16 and '17 EPS estimates by $0.02 and $0.10 to $8.81 and $9.79. LH reported Q3 operating EPS of $2.25 vs $2.07, $0.04. Q3 sales increased 4.5%. We expect 10.8% sales growth in '16 aided by pricing improvements due to growth in esoteric test volumes.
Laboratory Corporation of America® Holdings (LabCorp®) (LH) today announced it will participate at the 2016 Credit Suisse Nov-7th-Healthcare Conference. LabCorp’s presentation is planned for Monday, November 7, 2016 at 12:30 PM (ET).
Load Up The Truck Now LH! These guys are churning out huge winners I swear. Google STOCKTRADEVIDEO and you will see!